Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Clinical use of brain volumetry.
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions.
Acute disseminated encephalomyelitis.
Self-reported use of the upper limbs related to clinical tests in persons with multiple sclerosis.
Biological insights from 108 schizophrenia-associated genetic loci.
TREM2 regulates microglial cell activation in response to demyelination in vivo.
The role of IL-17 in CNS diseases.
Intestinal Microbiota as Modulators of the Immune System and Neuroimmune System: Impact on the Host Health and Homeostasis.
Aerobic Fitness Is Associated with Inhibitory Control in Persons with Multiple Sclerosis.
Burden of risk variants correlates with phenotype of multiple sclerosis.
Central Autonomic Dysfunction Delays Recovery of Fingolimod Induced Heart Rate Slowing.
Pain-related mood influences pain perception differently in fibromyalgia and multiple sclerosis.
A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya® (PASSOS)
Smoking increases the risk of multiple sclerosis in Queensland, Australia.
Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.
Automated White Matter Hyperintensity Detection in Multiple Sclerosis Using 3D T2 FLAIR.
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling.
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder.
The role of complement in inflammatory diseases from behind the scenes into the spotlight.
A Helminth Protease Inhibitor Modulates the Lipopolysaccharide-Induced Proinflammatory Phenotype of Microglia in vitro.
Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients.
Regulatory T cell proliferative potential is impaired in human autoimmune disease.
Astrogliosis as a therapeutic target for neurodegenerative diseases.

Pages